Craig-Hallum initiated coverage of BioHarvest Sciences (BHST) with a Buy rating and $15 price target
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BHST:
- BioHarvest Sciences to Announce Q1 2025 Financial Results
- BioHarvest Sciences participates in a conference call with Maxim Group
- BioHarvest Sciences: Strong Financial Performance and Strategic Expansion Drive Buy Rating
- BioHarvest Sciences Reports Strong Revenue Growth and Strategic Expansion
- BioHarvest Sciences Reports Strong Growth Amid Challenges